Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-25-065487
Filing Date
2025-03-27
Accepted
2025-03-27 16:01:39
Documents
90
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d789305d10k.htm   iXBRL 10-K 1752853
2 EX-3.1 d789305dex31.htm EX-3.1 33399
3 EX-19.1 d789305dex191.htm EX-19.1 56287
4 EX-23.1 d789305dex231.htm EX-23.1 2448
5 EX-31.1 d789305dex311.htm EX-31.1 6629
6 EX-31.2 d789305dex312.htm EX-31.2 6587
7 EX-32.1 d789305dex321.htm EX-32.1 3978
8 EX-32.2 d789305dex322.htm EX-32.2 3936
14 GRAPHIC g789305g25i61.jpg GRAPHIC 56490
15 GRAPHIC g789305g26n91.jpg GRAPHIC 94060
16 GRAPHIC g789305g42k03.jpg GRAPHIC 106796
17 GRAPHIC g789305g52l73.jpg GRAPHIC 67456
18 GRAPHIC g789305g61o00.jpg GRAPHIC 151870
19 GRAPHIC g789305g66a69.jpg GRAPHIC 65977
20 GRAPHIC g789305g82l34.jpg GRAPHIC 67676
  Complete submission text file 0001193125-25-065487.txt   8962081

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA vinc-20241231.xsd EX-101.SCH 52661
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vinc-20241231_cal.xml EX-101.CAL 43019
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vinc-20241231_def.xml EX-101.DEF 270296
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20241231_lab.xml EX-101.LAB 450716
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20241231_pre.xml EX-101.PRE 392241
93 EXTRACTED XBRL INSTANCE DOCUMENT d789305d10k_htm.xml XML 932936
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39244 | Film No.: 25779193
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)